Anixa Biosciences Announced Publication of Peer-Reviewed Journal Article Highlighting Ovarian Cancer Vaccine Technology
On Jun. 21, 2022, Anixa Biosciences announced the publication of a peer-reviewed journal article in Clinical and Experimental…
On Jun. 21, 2022, Anixa Biosciences announced the publication of a peer-reviewed journal article in Clinical and Experimental…
On Jun, 15, 2022, a multidisciplinary team of scientists, announced they had obtained and studied ancient Y. pestis…
On Jun. 7, 2022, Zoetis announced an agreement to acquire Basepaws, a privately held petcare genetics company, which…
On Jun. 2, 2022, the National Institutes of Health (NIH) reported that the Age-Related Eye Disease Studies (AREDS…
May 27, 2022, the National Cancer Institute (NCI) truncated the just-renewed five-year Cancer Center Support Grant held by…
On Apr. 28, 2022, the Ministry of Health of the Democratic Republic of the Congo declared an outbreak…
On Apr. 22, 2022, Stanford University announced it was awarded a $75 million gift from Nike co-founder Phil…
On Apr. 6, 2022, a new study in the Journal of Clinical Oncology showed that women receiving certain…
On Mar. 10, 2022, Cocrystal Pharma announced dosing of the first subjects in a Phase 1 clinical trial…
On Mar. 2, 2022, the U.S. Department of Agriculture’s Animal and Plant Health Inspection Service (APHIS) confirmed the…
On Feb. 28, 2022, the Patent and Trial Appeal Board of the U.S. Patent and Trademark Office (USPTO)…
On Feb. 22, 2022, Washington University in St. Louis announced that a blood test developed at the University’s…
On Feb. 1, 2022, University of Virginia Cancer Center announced it had been awarded a Comprehensive Cancer Center…
On Feb. 7, 2022, researchers at Washington University School of Medicine in St. Louis announced an analysis of…
On Feb. 2, 2022, a new analysis of the first two patients treated in a clinical trial with…
The Evolution of CRISPR illustrates its climb out of the primordial ocean on the backs of eukaryotic cells…
On Jan. 6, 2022, two new studies published in the journal Current Biology showed that environmental DNA (eDNA)…
On Dec. 28, 2021, Pacific Biosciences announced that its new HiFiViral SARS-CoV-2 solution had successfully sequenced and captured…
On Dec. 16, 2021, the Ebola outbreak that erupted in the Democratic Republic of the Congo’s North Kivu…
On Dec. 8, 2021, in a large-scale study of people from diverse ancestries, researchers narrowed down the number…
On Nov. 17, 2021, Pacific Northwest National Laboratory (PNNL) announced researchers had compiled the most comprehensive road map…
On Nov. 16, 2021, Illumina and Genetic Alliance announced the creation of the iHope Genetic Health program aimed…
On Nov. 14, 2021, the Calgary city council voted to reinstate fluoridation in Calgary’s waters. The count was…
On Nov. 8, 2021, Cocrystal Pharma announced that its SARS-CoV-2 main protease inhibitors showed potent in vitro pan-viral…
On Oct. 29, 2021, Oregon Health & Science University’s (OHSU) board of directors approved a project to expand…
On Oct. 26, 2021, Anixa Biosciences announced that, in conjunction with its partner, Cleveland Clinic, it had commenced…
On Oct. 19, 2021, the first investigational transplant of a genetically engineered, nonhuman kidney to a human body…
On Oct. 15, 2021, Roche announced that the U.S. Food and Drug Administration (FDA) had approved Tecentriq (atezolizumab)…
On Oct. 12, 2021, National Resilience announced a strategic collaboration with Children’s Hospital of Philadelphia (CHOP) to implement…
On Oct. 8, 2021, the Ministry of Health of the Democratic Republic of the Congo announced that a…